Tasnia Ahmed

Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study

Inês Pires da Silva, Tasnia Ahmed, Irene L. M. Reijers et al. · The Lancet Oncology · 2021 · 215 citations

Medicine, Oncology, Pharmacotherapy +16

Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial

Angela Hong, Gerald B. Fogarty, Kari Dolven-Jacobsen et al. · Journal of Clinical Oncology · 2019 · 108 citations

Medicine, Oncology, Surgery +17

Close proximity of immune and tumor cells underlies response to anti-PD-1 based therapies in metastatic melanoma patients

Tuba N. Gide, Inês Pires da Silva, Camelia Quek et al. · OncoImmunology · 2019 · 99 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

Prachi Bhave, Tasnia Ahmed, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 65 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites

Jordan W. Conway, Robert V. Rawson, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 58 citations · Full text

Medicine, Immunology, Oncology +17